TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Use this TGTX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TGTX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TGTX SEC filings page. Lician reads the product cache first so this HTML stays unique to TG Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full TGTX income, balance, and cash tables.